Clinical Trial Update: A Study to Investigate the Effect of Different Particle Sizes on the Single-dose Pharmacokinetics of Rilpivirine After Intramuscular Injection of a Long-acting Nanosuspension in Healthy Participants [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluated how different particle sizes affect the single-dose pharmacokinetics of a long-acting rilpivirine nanosuspension given by in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Rilpivirine long-acting nanosuspension (rilpivirine)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Healthy | Phase 1 | Status: COMPLETED